Neuromod

Neuromod company information, Employees & Contact Information

Explore related pages

Related company profiles:

Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Looking for a particular Neuromod employee's phone or email?

Neuromod Questions

News

Neuromod Closes €10 Million Financing to Accelerate Commercialisation - PR Newswire UK

Neuromod Closes €10 Million Financing to Accelerate Commercialisation PR Newswire UK

Neuromod Publishes Further Research Showing Breakthrough in Tinnitus Treatment, Availability of Lenire Expanded in Norway - NTB Kommunikasjon

Neuromod Publishes Further Research Showing Breakthrough in Tinnitus Treatment, Availability of Lenire Expanded in Norway NTB Kommunikasjon

FDA Grants Lenire® Tinnitus Treatment Device De Novo Approval - PR Newswire

FDA Grants Lenire® Tinnitus Treatment Device De Novo Approval PR Newswire

91% of Compliant Patients Report Long Term Tinnitus Relief in Large Scale Clinical Trial. - Via Ritzau

91% of Compliant Patients Report Long Term Tinnitus Relief in Large Scale Clinical Trial. Via Ritzau

Neuromod Publishes Results of Tinnitus Study Utilizing Non-invasive Stimulation Device - The Hearing Review

Neuromod Publishes Results of Tinnitus Study Utilizing Non-invasive Stimulation Device The Hearing Review

Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study - Science | AAAS

Bimodal neuromodulation combining sound and tongue stimulation reduces tinnitus symptoms in a large randomized clinical study Science | AAAS

FDA approves Lenire device by Neuromod for tinnitus treatment option for US veterans - Indian Pharma Post

FDA approves Lenire device by Neuromod for tinnitus treatment option for US veterans Indian Pharma Post

Neuromod Devices Closes €30 Million Financing to Expand Availability of Tinnitus Treatment Device Lenire® - PR Newswire

Neuromod Devices Closes €30 Million Financing to Expand Availability of Tinnitus Treatment Device Lenire® PR Newswire

Frost & Sullivan Recognizes Neuromod Devices with the 2023 New Product Innovation Award for Developing a Robust Solution That Meets Tinnitus Patients' Needs - PR Newswire Canada

Frost & Sullivan Recognizes Neuromod Devices with the 2023 New Product Innovation Award for Developing a Robust Solution That Meets Tinnitus Patients' Needs PR Newswire Canada

Neuromod Raises $12.4 Million in Series B Funding for Lenire Tinnitus Treatment Device - The Hearing Review

Neuromod Raises $12.4 Million in Series B Funding for Lenire Tinnitus Treatment Device The Hearing Review

Lenire®, the treatment device shown to reduce tinnitus symptoms in 95% of patients, is now available in Denmark - Via Ritzau

Lenire®, the treatment device shown to reduce tinnitus symptoms in 95% of patients, is now available in Denmark Via Ritzau

Lenire®, the treatment device shown to reduce tinnitus symptoms in 86.2% of patients, is now available in Norway - NTB Kommunikasjon

Lenire®, the treatment device shown to reduce tinnitus symptoms in 86.2% of patients, is now available in Norway NTB Kommunikasjon

Neuromod's FDA-Approved Lenire Device Now a Treatment Option for 2.9 Million US Veterans with Tinnitus - PR Newswire

Neuromod's FDA-Approved Lenire Device Now a Treatment Option for 2.9 Million US Veterans with Tinnitus PR Newswire

Nature Communications Medicine Publishes Positive, Real World Data for Tinnitus Patients Treated with Unique, FDA Approved Stimulation Device - PR Newswire

Nature Communications Medicine Publishes Positive, Real World Data for Tinnitus Patients Treated with Unique, FDA Approved Stimulation Device PR Newswire

Controlled Clinical Trial Results for Lenire Tinnitus Treatment Device Published in Nature Communications - NTB Kommunikasjon

Controlled Clinical Trial Results for Lenire Tinnitus Treatment Device Published in Nature Communications NTB Kommunikasjon

Neuromod appoints Eric Timm as US Chief Executive Officer - PR Newswire

Neuromod appoints Eric Timm as US Chief Executive Officer PR Newswire

Lenire from Neuromod delivers tinnitus improvement 'not demonstrated for any other treatment,' according to expert consensus - PR Newswire

Lenire from Neuromod delivers tinnitus improvement 'not demonstrated for any other treatment,' according to expert consensus PR Newswire

Controlled Clinical Trial Results for FDA-Approved Tinnitus Treatment Device Lenire Published in Nature Communications - PR Newswire

Controlled Clinical Trial Results for FDA-Approved Tinnitus Treatment Device Lenire Published in Nature Communications PR Newswire

Top Neuromod Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant